The point is that the same MD said that HPA was on the shelf until core elements of the business plan were finalised. And now, here it is, being touted again. Not a good sign. At best, a distraction for shareholders. At worst, a hint at yet another repivot if/when this one fails.
Ann: Andromeda progresses HPA product development, page-8
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.002(11.1%) |
Mkt cap ! $49.76M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.5¢ | $797.4K | 49.05M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2397883 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 2031381 | 4 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| ADN (ASX) Chart |